Blueprint Medicines
Blueprint Medicines offers a summer internship in biostatistics focused on applied statistics related to clinical development. Interns gain experience working on projects involving study designs, data collection, data review, cleaning, and analysis methodologies within a biostatistics team.
Headquarters
Cambridge, Massachusetts, United States
Company Size
501-1000 employees
Founded
2011
Blueprint Medicines is a biotechnology company focused on developing targeted therapies for patients with cancer and rare diseases. The company uses precision medicine and genomics to design drugs that selectively inhibit disease-causing proteins, particularly kinase-driven cancers and systemic mastocytosis.
Sanofi To Buy Blueprint Medicines For Up To $9.5B: Retail Sees More Acquisition Offers From European Pharma Companies
4 days ago
Blueprint Medicines, a Sanofi Company, Announces Four-Year PIONEER Data Showing Sustained Benefit and Long-Term Safety of AYVAKIT® (avapritinib) in Indolent Systemic Mastocytosis
2 weeks ago
Blueprint’s rare disease drug Ayvakit shows long-term benefit
1 week ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Blueprint Medicines.
Blueprint Medicines Stock Soars as Biotech Agrees to Over $9B Sanofi Takeover
Jun 2, 2025
2026 - Biostatistics Intern
Roche
Senior Director, Biostatistics – Late Phase
Revolution Medicines
Intern, Biostatistics
Eikon Therapeutics
Associate Director, Biostatistics
Relay Therapeutics
Associate Director, Biostatistics (2)
CSL Behring Australia
Senior Manager, Biostatistics - Oncology
Regeneron Pharmaceuticals